About Xcelience
Xcelience is a Healthcare company based in Tampa (United States) founded in 1997, and was acquired by Capsugel in December 2015. CDMO services from preformulation to clinical logistics are provided. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
Xcelience was founded in 1997 in Tampa, United States, and operates as a contract development and manufacturing organization in the pharmaceutical sector. Early-phase small molecule development is specialized in, with services encompassing preformulation, analytical testing, formulation development, stability management, GMP clinical manufacturing, small-scale commercial production, and clinical supplies packaging along with logistics for Phase I to III trials.
- Headquarters Tampa, United States
- Stage Acquired
- SectorsHealthcare
- Website xcelience.com
- Social LinkedIn X
- Acquired by Capsugel (Dec 2015)
Investors in Xcelience
Xcelience has secured backing from 1 investor. Prominent investors backing the company include Capsugel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Dosage forms are delivered for preclinical, clinical, and commercial supply. | 1875 | capsugel.com | Morristown, United States |
Investor details for Xcelience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Xcelience
2 dated milestones of Xcelience across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Xcelience is founded.
- Exit Acquired by Capsugel.
Web traffic of Xcelience
Websites that share an audience with Xcelience (xcelience.com).
Websites whose visitors overlap most with Xcelience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| westpharma.com | 28% | 101.1K | #397,912 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Xcelience (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Xcelience
Complete news archive for Xcelience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xcelience
Xcelience was founded in 1997.
Xcelience is headquartered in Tampa, United States. It is registered at Tampa, Florida, United States.
Xcelience was founded in 1997 in Tampa, United States, and operates as a contract development and manufacturing organization in the pharmaceutical sector. Early-phase small molecule development is specialized in, with services encompassing preformulation, analytical testing, formulation development, stability management, GMP clinical manufacturing, small-scale commercial production, and clinical supplies packaging along with logistics for Phase I to III trials.
Xcelience has 1 investor. Key investors include Capsugel.
Yes. Xcelience was acquired by Capsugel in December 2015.